MelUstadweb.png

Mel Ustad
Director of Commercialization at the Governor's Office of Economic Development.

mdt.png 

Keynote >> MIKE THOMPSON,
Dr. Michael Thompson is Vice President of PartnerDevelopment with Benson Hill Biosystems. He is personally passionate about eliminating poverty and hunger and professionally responsible for improving crop performance through adoption of Benson Hill’s proprietary computational and systems biology platform, CropOS™. Prior to joining Benson Hill, he served as Director of GlobalSales and Market Development for Illumina’s Agriculture business. He previously the DNA Technologies division of BioDiagnostics, Inc. and held leadership positions in research and technology development at Monsanto.


Thompson for SD Biotech Assoc_Oct2018.pdf
 

England.png

Kristi Egland, PhD
Kristi Egland, PhD attended college at Washington University in St. Louis, MO. She received her Ph.D. in Molecular Biology from the University of Iowa. After studying immunotherapies as a post-doctoral fellow at the National Cancer Institute in Bethesda, MD, she joined Sanford Research and established her breast cancer research program.

 Hennings.png DR. JANE CHRISTOPHER-HENNINGS
Center For Biologics Research & Commercialization Dr. Jane Christopher-Hennings is the PI for the Governor’s Office of Economic  Development Center for Biologics Research & Commercialization, Head of the SDSU, Veterinary and Biomedical Sciences Department and Director of the SD Animal Disease Research and Diagnostic Laboratory.  She has BS and MS Degrees from the University of Wisconsin-Madison; DVM from the University of Minnesota and is currently a Full Professor at SDSU. She has published >70 manuscripts and 6 book chapters while successfully obtaining grant funding (>$7 million) and intellectual property license agreements and patent applications.  
RobbWinters.png  ROBB WINTERS, Ph.D.
South Dakota Biofilm Science and Engineering Center - NSF EPSCoR
Robb Winter is the department head and professor of chemical and biological engineering at South Dakota School of Mines & Technology. He current leads the research effort of the National Science Foundation Track 1 proposal to create the SD Biofilm Science and Engineering Center and is program director for more than $8 million in contracts with the U.S. Air Force to conserve energy at forward operating bases. In that role he has guided the development of the Composites and Polymer Engineering Laboratory and collaborated on the creation of the Center for Bioprocessing Research and Development.
 
 BillGibbons.png

WILLIAM GIBBONS, Ph.D.              
SD Oilseeds Research Initiative
Gibbons is an accomplished researcher focused on applied microbiology and biotechnology, specifically in value addition to agricultural products through bioprocessing. Most of the students he has trained have gone on to work in the biotechnology industry. He has practiced and promoted interdisciplinary research and has a strong network of collaborators.

SD OIlseed Initiative SD Bio 2018.pptx

CB.png  CHRISTOPH L. BAUSCH, Ph.D.
SAB Biotherapeutics
Dr. Christoph L. Bausch is the chief science officer of SAB Biotherapeutics, a clinical-stage biopharmaceutical development company commercializing the first-of-its-kind immunotherapy platform to produce full human polyclonal (IgG) antibodies from bovine –The DiversitAb™ Platform. Dr. Bausch is responsible for antibody and antigen production, quality control laboratories, research collaborations, grant funding and clinical studies. Prior to SAB, Dr. Bausch worked in business development for global biorefining leader, Poet, LLC, where he structured strategic partnerships, prospected and vetted new technologies, and streamlined R&D. He also held research and commercialization roles for Fortune 500 life science company Sigma-Aldrich.
 

Ehli.png 

massy.png

scholl.png

ERIK EHLI, Ph.D., BSN
Avera Institute For Human Genetics
Dr. Erik Ehli is the Scientific Director at the Avera Institute for Human Genetics and an Assistant Professor within the University Of South Dakota Department Of Psychiatry. Dr. Ehli’s research interests lie in the molecular genetic mechanisms of complex diseases, with a strong focus on twin, cancer, and pharmacogenetics.

 

 

 

 

ADRIANNE MASSEY, Ph.D., BIO
Dr. Adrianne Massey began her professional career as a faculty member in the Biology Department of NC State University. She left academia to serve as Vice President of the NC Biotechnology Center, where she directed the Center's award-winning biotechnology education, work force training and public outreach programs.
Most recently, Dr. Massey served as Managing Director for Science and Regulatory Affairs at BIO in Washington, D.C.
She is the co-author of three textbooks on the science, applications and societal issues of medical, agricultural and industrial biotechnology.

AMassey SD BIO messages gene editing.pptx




DANIEL SCHOLL Ph.D., SDSU
Daniel Scholl is vice president for research and economic development at South Dakota State University. Scholl joined SDSU in 2011 as as associate dean for research of the College of Agriculture and Biological Sciences and director of the South Dakota Agricultural Experiment Station. Previously at the University of Montreal, he led a team that founded an international research consortium with the Canadian Natural Sciences and Engineering Research Council and several industry partners.


 Wiener.png RICHARD E. WEINER, moderator
Fredrikson & Byron P.A.
Richard Weiner is an international renewable energy lawyer in Fredrikson & Byron’s Renewable Energy Group and is chair of the firm’s International Group. Rich assists clients with renewable energy projects in the United States and overseas. Rich focuses specifically on contract matters, joint ventures, partnerships, strategic alliances, mergers and acquisitions, technology licensing, and dispute resolution in the renewable energy industry. 
 Steinle.png JEFFREY STEINLE, Esq.,
Fredrikson & Bryon, P.A.
Jeffery Steinle is a corporate attorney with Frederikson & Byron who advises life science companies executing M&A, divestiture, financing, joint venture, licensing and community transactions. He also serves as general counsel to digital health companies as they navigate the myriad legal issues related to the growing use of artificial intelligence, smart algorithms and big data in medical technology. He was recently the general counsel of Vios Medical, Inc., an emerging growth health care information technology company with an IoT-based patient management platform delivered as a service, prior to its sale to Murata Manufacturing Co. in the fall of 2017. Before joining Fredrikson & Byron, Jeff founded and led a consulting firm that provided general counsel services and strategic advice to life science companies and was vice president of business law and deputy general counsel of SuperValu, Inc.

 State of Investing Life Sciences 2018.ppt
 Penny.png

PENNY SATTGAST
PCS Biotech Services
Prior to founding PCS Biotech Services in 2017, Penny worked for Elanco and served as a clinical trial study director. She brings 15 years of clinical, laboratory, quality and regulatory experience to her business, and has an MS in biology from South Dakota State University.

PCS Biotech BioSummit FINAL presentation04OCT2018.pptx

BKE.png  KIPP ERICKSON, Ph.D.
RTI, LLC
Dr. Kipp Erickson is chief operating officer of Brookings-based RTI, LLC. He joined the company in July 2018. His career includes roles at Procter & Gamble Pharmaceuticals, Pharmacia, Pfizer and Zoetis, He serves as VP of technology & commercialization at Intrexon and, recently, as director of translational medicine at the College of Veterinary Medicine at Michigan State University. He has extensive experience in pharma/biopharma research and product development, strategy and business development, commercialization, licensing and patenting. He is also an expert resource in product concept development and creation of intellectual property, recognizing opportunities from academic research and how to evolve them toward invention disclosures, and forming connections with potential external partners.